News
FDA Shuts Down Sarepta Gene Therapy Trials
Digest more
FDA places clinical hold on Sarepta's LGMD gene therapy trials after three deaths and revokes platform tech designation due ...
The FDA has placed multiple investigational gene therapy clinical trials on hold, signaling broader platform concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback